299 related articles for article (PubMed ID: 19072437)
1. Familial pancreatic cancer: from genes to improved patient care.
Hruban RH; Klein AP; Eshleman JR; Axilbund JE; Goggins M
Expert Rev Gastroenterol Hepatol; 2007 Oct; 1(1):81-8. PubMed ID: 19072437
[TBL] [Abstract][Full Text] [Related]
2. Familial pancreatic cancer.
Klein AP; Hruban RH; Brune KA; Petersen GM; Goggins M
Cancer J; 2001; 7(4):266-73. PubMed ID: 11561603
[TBL] [Abstract][Full Text] [Related]
3. [Familial pancreatic cancer].
Zalatnai A
Magy Onkol; 2006; 50(2):163-8. PubMed ID: 16888680
[TBL] [Abstract][Full Text] [Related]
4. No evidence for germline mutations of the LKB1/STK11 gene in familial pancreatic carcinoma.
Grützmann R; McFaul C; Bartsch DK; Sina-Frey M; Rieder H; Koch R; McCarthy E; Greenhalf W; Neoptolemos JP; Saeger HD; Pilarsky C
Cancer Lett; 2004 Oct; 214(1):63-8. PubMed ID: 15331174
[TBL] [Abstract][Full Text] [Related]
5. BRCA2 mutations as a universal risk factor for pancreatic cancer has a limited role in Korean ethnic group.
Cho JH; Bang S; Park SW; Chung JB; Song SY
Pancreas; 2008 May; 36(4):337-40. PubMed ID: 18437078
[TBL] [Abstract][Full Text] [Related]
6. A carrier of both MEN1 and BRCA2 mutations: case report and review of the literature.
Ghataorhe P; Kurian AW; Pickart A; Trapane P; Norton JA; Kingham K; Ford JM
Cancer Genet Cytogenet; 2007 Dec; 179(2):89-92. PubMed ID: 18036394
[TBL] [Abstract][Full Text] [Related]
7. Molecular pathogenesis of pancreatic cancer.
Maitra A; Kern SE; Hruban RH
Best Pract Res Clin Gastroenterol; 2006 Apr; 20(2):211-26. PubMed ID: 16549325
[TBL] [Abstract][Full Text] [Related]
8. Familial melanoma, pancreatic cancer and germline CDKN2A mutations.
Goldstein AM
Hum Mutat; 2004 Jun; 23(6):630. PubMed ID: 15146471
[TBL] [Abstract][Full Text] [Related]
9. Predicting the risk of pancreatic cancer: on CDKN2A mutations in the melanoma-pancreatic cancer syndrome in Italy.
Ghiorzo P; Gargiulo S; Nasti S; Pastorino L; Battistuzzi L; Bruno W; Bonelli L; Taveggia P; Pugliese V; Borgonovo G; Mastracci L; Fornarini G; Romagnoli P; Iiritano E; Savarino V; Bianchi-Scarrà G
J Clin Oncol; 2007 Nov; 25(33):5336-7; author reply 5337-8. PubMed ID: 18024887
[No Abstract] [Full Text] [Related]
10. CDKN2A is the main susceptibility gene in Italian pancreatic cancer families.
Ghiorzo P; Fornarini G; Sciallero S; Battistuzzi L; Belli F; Bernard L; Bonelli L; Borgonovo G; Bruno W; De Cian F; Decensi A; Filauro M; Faravelli F; Gozza A; Gargiulo S; Mariette F; Nasti S; Pastorino L; Queirolo P; Savarino V; Varesco L; Scarrà GB;
J Med Genet; 2012 Mar; 49(3):164-70. PubMed ID: 22368299
[TBL] [Abstract][Full Text] [Related]
11. Heterogeneity of risk for melanoma and pancreatic and digestive malignancies: a melanoma case-control study.
Rutter JL; Bromley CM; Goldstein AM; Elder DE; Holly EA; Guerry D; Hartge P; Struewing JP; Hogg D; Halpern A; Sagebiel RW; Tucker MA
Cancer; 2004 Dec; 101(12):2809-16. PubMed ID: 15529312
[TBL] [Abstract][Full Text] [Related]
12. Increased prevalence of the BRCA2 polymorphic stop codon K3326X among individuals with familial pancreatic cancer.
Martin ST; Matsubayashi H; Rogers CD; Philips J; Couch FJ; Brune K; Yeo CJ; Kern SE; Hruban RH; Goggins M
Oncogene; 2005 May; 24(22):3652-6. PubMed ID: 15806175
[TBL] [Abstract][Full Text] [Related]
13. Familial pancreatic cancer syndromes.
Habbe N; Langer P; Sina-Frey M; Bartsch DK
Endocrinol Metab Clin North Am; 2006 Jun; 35(2):417-30, xi. PubMed ID: 16632103
[TBL] [Abstract][Full Text] [Related]
14. Hereditary pancreatic cancer: a clinical perspective.
Greer JB; Lynch HT; Brand RE
Best Pract Res Clin Gastroenterol; 2009; 23(2):159-70. PubMed ID: 19414143
[TBL] [Abstract][Full Text] [Related]
15. PALB2 germline mutations in familial breast cancer cases with personal and family history of pancreatic cancer.
Peterlongo P; Catucci I; Pasquini G; Verderio P; Peissel B; Barile M; Varesco L; Riboni M; Fortuzzi S; Manoukian S; Radice P
Breast Cancer Res Treat; 2011 Apr; 126(3):825-8. PubMed ID: 21184274
[No Abstract] [Full Text] [Related]
16. Inherited pancreatic cancer: improvements in our understanding of genetics and screening.
Rulyak SJ; Brentnall TA
Int J Biochem Cell Biol; 2004 Aug; 36(8):1386-92. PubMed ID: 15147717
[TBL] [Abstract][Full Text] [Related]
17. International registries of families at high risk of pancreatic cancer.
Greenhalf W; Malats N; Nilsson M; Bartsch D; Neoptolemos J
Pancreatology; 2008; 8(6):558-65. PubMed ID: 18818508
[TBL] [Abstract][Full Text] [Related]
18. Familial pancreatic cancer: a review.
Lynch HT; Smyrk T; Kern SE; Hruban RH; Lightdale CJ; Lemon SJ; Lynch JF; Fusaro LR; Fusaro RM; Ghadirian P
Semin Oncol; 1996 Apr; 23(2):251-75. PubMed ID: 8623061
[TBL] [Abstract][Full Text] [Related]
19. Identification and screening of individuals at increased risk for pancreatic cancer with emphasis on known environmental and genetic factors and hereditary syndromes.
Chu D; Kohlmann W; Adler DG
JOP; 2010 May; 11(3):203-12. PubMed ID: 20442513
[TBL] [Abstract][Full Text] [Related]
20. Germ-line mutations, pancreatic inflammation, and pancreatic cancer.
Whitcomb D; Greer J
Clin Gastroenterol Hepatol; 2009 Nov; 7(11 Suppl):S29-34. PubMed ID: 19896094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
